Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies [Phase 2]
Phase II study of Folotyn with leucovorin to prevent or reduce mucositis in patients with relapsed or refractory peripheral T-cell lymphoma …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients [Phase 2]
Phase II trial evaluating gemcitabine plus romidepsin in relapsed/refractory peripheral T-cell lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL [Phase 3]
Phase 3 single-arm trial assessing pralatrexate for relapsed or refractory peripheral T-cell lymphoma completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib in combination with CHEP for peripheral T cell lymphoma is reported as ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas [Phase 2]
Phase 2 trial update for intravenous fenretinide emulsion in relapsed/refractory peripheral T-cell lymphoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma [Phase 3]
A Phase 3 trial comparing CDOP to CHOP for newly diagnosed peripheral T-cell lymphoma is being reported, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Alemtuzumab and CHOP in T-cell Lymphoma [Phase 3]
Phase 3 trial update investigating alemtuzumab with CHOP in peripheral T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating chidamide with cyclophosphamide, prednisone, and thalidomide for relapsed/refractory peripheral T cell l…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL [Phase 3]
Phase 3 trial comparing romidepsin alone to romidepsin plus pralatrexate in peripheral T-cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma [Phase 2]
Phase 2 clinical trial update for liposome-entrapped mitoxantrone hydrochloride injection in relapsed/refractory peripheral T-cell lymphoma …
-
FDA approval · 2018-11-27FDA Approved: ISTODAX — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for Istodax (romidepsin) from Celgene Corporation. The action updates regulatory labeling for the dr…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 trial update for E7777 in patients with Peripheral T-Cell Lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies [Phase 2]
Phase 2 trial of Deoxycoformycin (pentostatin) in lymphoid malignancies completed, studying Peripheral T-cell Lymphoma and Cutaneous T-cell …
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma [Phase 2]
Phase 2 clinical trial of bendamustine, carboplatin, and dexamethasone (BCD) for refractory or relapsed peripheral T-cell lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients [Phase 2]
Phase 2 clinical trial update evaluating chidamide in combination with CHOPE for peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib with ACVBP in peripheral T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell Lymphoma [Phase 2]
Phase 2 trial of selinexor in relapsed or refractory PTCL or CTCL; study terminated with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Treatment of Newly Diagnosed Peripheral T-cell Lymphoma [Phase 4]
A Phase 4 clinical trial update for treating newly diagnosed peripheral T-cell lymphoma is listed, with the status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma [Phase 3]
A Phase 3 trial evaluated alisertib (MLN8237) versus investigator's choice for relapsed or refractory peripheral T-cell lymphoma; the study …
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy with pralatrexate as first-line therapy for non-Hodgkin lymphomas, including various T-cel…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma [Phase 3]
Phase 3 trial comparing decitabine plus CHOP versus CHOP in untreated peripheral T-cell lymphoma evaluates efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas [Phase 4]
This is an update on a Phase 4 clinical trial evaluating a multi-agent chemotherapy regimen (cisplatin, ifosfamide, gemcitabine, L-asparagin…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating alisertib in combination with vorinostat in adults with relapsed or recurrent Hodgkin lymphoma, B-cell non-Hodgkin …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma
A completed clinical trial evaluated pralatrexate for relapsed or refractory peripheral T-cell lymphoma.
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating chidamide in combination with chemotherapy for peripheral T-cell lymphoma. The trial status is currently unknown.